Comparative activity of anticestode drugs—praziquantel, niclosamide and Compound 77–6, against Hymenolepis nana

1983 ◽  
Vol 57 (1) ◽  
pp. 31-36 ◽  
Author(s):  
Suman Gupta ◽  
J. C. Katiyar
Keyword(s):  
Drug Concentration ◽  
Hymenolepis Nana ◽  
Comparative Activity

AbstractThe activity, in terms of speed of action, of three anticestode drugs against Hymenolepis nana, both in vivo and in vitro, was investigated. Praziquantel was most effective in vivo, but had little action on adult worms and cysticercoids in vitro. Niclosamide, the least effective in vivo, was highly toxic in vitro. Compound 77–6 killed adult worms and cysticercoids in vitro in 10 min and 15 min respectively at 1000 μg/ml of drug concentration, but its in viro effect was intermediate between that of praziquantel and niclosamide.

Evaluation of Paclitaxel Nanocrystals In Vitro and In Vivo

Drug Research ◽  
2017 ◽  
Vol 68 (04) ◽  
pp. 205-212 ◽  
Author(s):  
Wanqing Li ◽  
Zhiguo Li ◽  
Lisha Wei ◽  
Aiping Zheng
Keyword(s):  
Drug Concentration ◽  
Antitumor Effects ◽  
High Drug ◽  
High Drug Concentration ◽  
Low Toxicity ◽  
Nanoparticle Drug Delivery ◽  
Antitumor Evaluation ◽  
Mcf 7

AbstractWe created a novel paclitaxel (PTX) nanoparticle drug delivery system and compared this to acommercial injection preparation to evaluate the antitumor effects for both formulations in vivo and in vitro.PTXnanocrystals were 194.9 nm with potential of −29.6 mV. Cytotoxicity tests indicated that both formulations had similar effects and cytotoxicity was dose- and time-dependent.Pharmacodynamics indicated that the drug concentration at the tumor was greater with PTX nanocrystals compared to commercial injection (P<0.01) and that drug accumulated more and for a longer duration. In vivo antitumor evaluation indicated significant antitumor effects and low toxicity of PTX nanocrystals. Moreover, bioimaging indicated that the PTX retention time in MCF-7-bearing mice was longer, especially at the tumor site, and this high drug concentration was maintained for a long time.Overall, PTX nanocrystalsare feasible and superior to traditional injection formulation chemotherapy.

scholarly journals Antiparasitary Activity Of The Juglone Compound: A Narrative Review

2021 ◽  
pp. 13
Author(s):  
◽  
Keyword(s):  
Mortality Rate ◽  
Leishmania Donovani ◽  
Inhibitory Concentration ◽  
Narrative Review ◽  
Hymenolepis Nana ◽  
Compound A ◽  
Living Organisms ◽  
Nanomolar Range

Objective: To report, based on the literature, the action of the compound 5-hydroxy-1,4-naphthoquinone against parasites (protozoa and helminths) that affect humans. Methods: This is a narrative review that used Pubmed and Google Scholar as a data tool. This work included articles published until September 2020 that were directly related to the use of the compound juglone in antiparasitic trials. Results: The compound juglone demonstrated promising effects as a human and animal antiparasitic substance. In protozoa, the Apicomplexo Toxoplasma gondii parasite showed a high mortality rate in concentrations of juglone in the nanomolar range. The juglone showed an average inhibitory concentration (IC50) of 1.62 µM, >100 µM, and 2.02 µM µM for Trypanosoma cruzi, T. brucei rhodesiense, and Leishmania donovani, respectively. Also, the juglone showed antihelmintic activity on Hymenolepis nana in mice, and on adult worms of Schistosoma mansoni (LE strain) with IC50 34.16 µM, 32.14 µM, and 25 µM in the 24h, 48h, and 72 h, respectively. Conclusion: The results published so far show the in vitro antiparasitic potential of juglone, and the need for further studies on the specific mode of action that interacts with parasites. Besides, the literature is still limited to studies that evaluate in vivo the compound juglone, requiring better information on its interaction with living organisms.

scholarly journals Nebulised Isotonic Hydroxychloroquine Aerosols for Potential Treatment of COVID-19

Pharmaceutics ◽  
2021 ◽  
Vol 13 (8) ◽  
pp. 1260
Author(s):  
Waiting Tai ◽  
Michael Yee Tak Chow ◽  
Rachel Yoon Kyung Chang ◽  
Patricia Tang ◽  
Igor Gonda ◽  
...  
Keyword(s):  
Drug Concentration ◽  
Systemic Exposure ◽  
Oral Route ◽  
Liquid Volume ◽  
Global Public Health ◽  
Promising Alternative ◽  
High Drug Concentration ◽  
Preclinical And Clinical Studies

The coronavirus disease 2019 (COVID-19) is an unprecedented pandemic that has severely impacted global public health and the economy. Hydroxychloroquine administered orally to COVID-19 patients was ineffective, but its antiviral and anti-inflammatory actions were observed in vitro. The lack of efficacy in vivo could be due to the inefficiency of the oral route in attaining high drug concentration in the lungs. Delivering hydroxychloroquine by inhalation may be a promising alternative for direct targeting with minimal systemic exposure. This paper reports on the characterisation of isotonic, pH-neutral hydroxychloroquine sulphate (HCQS) solutions for nebulisation for COVID-19. They can be prepared, sterilised, and nebulised for testing as an investigational new drug for treating this infection. The 20, 50, and 100 mg/mL HCQS solutions were stable for at least 15 days without refrigeration when stored in darkness. They were atomised from Aerogen Solo Ultra vibrating mesh nebulisers (1 mL of each of the three concentrations and, in addition, 1.5 mL of 100 mg/mL) to form droplets having a median volumetric diameter of 4.3–5.2 µm, with about 50–60% of the aerosol by volume < 5 µm. The aerosol droplet size decreased (from 4.95 to 4.34 µm) with increasing drug concentration (from 20 to 100 mg/mL). As the drug concentration and liquid volume increased, the nebulisation duration increased from 3 to 11 min. The emitted doses ranged from 9.1 to 75.9 mg, depending on the concentration and volume nebulised. The HCQS solutions appear suitable for preclinical and clinical studies for potential COVID-19 treatment.

scholarly journals Mechanisms of Acquired In Vivo and In Vitro Resistance to Voriconazole by Candida krusei following Exposure to Suboptimal Drug Concentration

2020 ◽  
Vol 64 (4) ◽  
Author(s):  
Elisabete Ricardo ◽  
Fréderic Grenouillet ◽  
Isabel M. Miranda ◽  
Raquel M. Silva ◽  
Guilluame Eglin ◽  
...  
Keyword(s):  
Kidney Transplant ◽  
Drug Concentration ◽  
Transplant Patient ◽  
Candida Krusei ◽  
Clinical Isolates ◽  
Kidney Transplant Patient ◽  
Content Type

ABSTRACT Five Candida krusei isolates (susceptible and resistant) recovered from the urine of a kidney transplant patient treated with voriconazole (VRC) 200 mg twice daily for 20 days were studied. Eight unrelated clinical isolates of C. krusei were exposed in vitro to VRC 0.001 μg/ml for 30 days. Development of VRC transient resistance occurred in vivo, and induction of permanent resistance occurred in vitro. Mostly, ABC1 and ERG11 genes were overexpressed, and a homozygous T418C mutation in the ERG11 gene was found.

Enhancement of intestinal eosinophilia duringHymenolepis nanainfection in mice

1996 ◽  
Vol 70 (1) ◽  
pp. 33-41 ◽  
Author(s):  
A. Niwa ◽  
T. Miyazato
Keyword(s):  
Periodate Oxidation ◽  
Chemotactic Activity ◽  
Proteinase K ◽  
Eosinophil Infiltration ◽  
Hymenolepis Nana ◽  
Chemical Treatments ◽  
Tissue Eosinophilia ◽  
Chemotactic Factors

AbstractThe ability ofHymenolepis nanaoncosphere extract to induce eosinophil chemotactic response was examinedin vitroandin vivo. The extract showed a chemotactic activity specific for eosinophils but not for neutrophils. Partially purified eosinophil chemotactic factors (ECFs) from the oncosphere extract showed apparent molecular mass from 5.5 to 9.6kDa and 30 to 40kDa. These were resistant to heating and proteinase K digestion but sensitive to periodate oxidation. Peritoneal injection of the crude extract or partially purified ECFs to mice resulted in a preferential eosinophil infiltration. The chemotactic activity for eosinophils was not separable from the adhesion molecule expression or oxygen radical-inducing activity by means of chromatography or chemical treatments. Furthermore, histological examination demonstrated a marked tissue eosinophilia aroundH. nanalarvae in the intestinal lamina propria of both humoral and cell-mediated immunodeficiency mice. The present findings suggest thatH. nanaoncosphere-derived molecules facilitatein vivothe intestinal eosinophilia during the infection.

scholarly journals In vitro and in vivo anthelmintic activity of seed extract of Coriandrum sativum compared to Niclosamid against Hymenolepis nana infection

2015 ◽  
Vol 40 (4) ◽  
pp. 1307-1310 ◽  
Author(s):  
Samaneh Hosseinzadeh ◽  
Maryam Jamshidian Ghalesefidi ◽  
Mehdi Azami ◽  
Mohammad Ali Mohaghegh ◽  
Seyed Hossein Hejazi ◽  
...  
Keyword(s):  
Anthelmintic Activity ◽  
Seed Extract ◽  
Coriandrum Sativum ◽  
Hymenolepis Nana

scholarly journals A Dynamic Stress Model Explains the Delayed Drug Effect in Artemisinin Treatment of Plasmodium falciparum

2017 ◽  
Vol 61 (12) ◽  
Author(s):  
Pengxing Cao ◽  
Nectarios Klonis ◽  
Sophie Zaloumis ◽  
Con Dogovski ◽  
Stanley C. Xie ◽  
...  
Keyword(s):  
Drug Concentration ◽  
Dynamic Stress ◽  
Explanatory Power ◽  
Artemisinin Resistance ◽  
Laboratory Strain ◽  
Stress Model ◽  
Killing Rate ◽  
Dosing Regimens

ABSTRACT Artemisinin resistance constitutes a major threat to the continued success of control programs for malaria, particularly in light of developing resistance to partner drugs. Improving our understanding of how artemisinin-based drugs act and how resistance manifests is essential for the optimization of dosing regimens and the development of strategies to prolong the life span of current first-line treatment options. Recent short-drug-pulse in vitro experiments have shown that the parasite killing rate depends not only on drug concentration but also the exposure time, challenging the standard pharmacokinetic-pharmacodynamic (PK-PD) paradigm in which the killing rate depends only on drug concentration. Here, we introduce a dynamic stress model of parasite killing and show through application to 3D7 laboratory strain viability data that the inclusion of a time-dependent parasite stress response dramatically improves the model's explanatory power compared to that of a traditional PK-PD model. Our model demonstrates that the previously reported hypersensitivity of early-ring-stage parasites of the 3D7 strain to dihydroartemisinin compared to other parasite stages is due primarily to a faster development of stress rather than a higher maximum achievable killing rate. We also perform in vivo simulations using the dynamic stress model and demonstrate that the complex temporal features of artemisinin action observed in vitro have a significant impact on predictions for in vivo parasite clearance. Given the important role that PK-PD models play in the design of clinical trials for the evaluation of alternative drug dosing regimens, our novel model will contribute to the further development and improvement of antimalarial therapies.

scholarly journals Combined Methodologies for Determining In Vitro Bioavailability of Drugs and Prediction of In Vivo Bioequivalence From Pharmaceutical Oral Formulations

2021 ◽  
Vol 9 ◽  
Author(s):  
A. De Simone ◽  
L. Davani ◽  
S. Montanari ◽  
V. Tumiatti ◽  
S. Avanessian ◽  
...  
Keyword(s):  
Drug Release ◽  
Drug Concentration ◽  
Dissolution Test ◽  
Brand Name ◽  
Artificial Membrane ◽  
New Approach ◽  
Oral Formulations ◽  
Permeability Assay

With the aim of developing an in vitro model for the bioavailability (BA) prediction of drugs, we focused on the study of levonorgestrel (LVN) released by 1.5 mg generic and brand-name tablets. The developed method consisted in combining a standard dissolution test with an optimized parallel artificial membrane permeability assay (PAMPA) to gain insights into both drug release and gastrointestinal absorption. Interestingly, the obtained results revealed that the tablet standard dissolution test, combined with an optimized PAMPA, highlighted a significant decrease in the release (15 ± 0.01 μg min−1 vs 30 ± 0.01 μg min−1) and absorption (19 ± 7 × 10–6 ± 7 cm/s Pe vs 41 ± 15 × 10–6 cm/s Pe) profiles of a generic LVN tablet when compared to the brand-name formulation, explaining unbalanced in vivo bioequivalence (BE). By using this new approach, we could determine the actual LVN drug concentration dissolved in the medium, which theoretically can permeate the gastrointestinal (GI) barrier. In fact, insoluble LVN/excipient aggregates were found in the dissolution media giving rise to non-superimposable dissolution profiles between generic and brand-name LVN tablets. Hence, the results obtained by combining the dissolution test and PAMPA method provided important insights confirming that the combined methods can be useful in revealing crucial issues in the prediction of in vivo BE of drugs.

Sign in / Sign up

Export Citation Format

Share Document